Andres Lescano

Dr. Andres Lescano

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in The Lancet
Verified
Journal Article
Closed access
DBDouglas S Berkman
Douglas S Berkman
ALAndres Lescano
Andres Lescano
RGRobert H Gilman
Robert H Gilman
SLSonia L Lopez
Sonia L Lopez
MBMaureen M Black
Maureen M Black

1 February 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JKJames G. Kublin
James G. Kublin
FDFraction K. Dzinjalamala
Fraction K. Dzinjalamala
DKDeborah D. Kamwendo
Deborah D. Kamwendo
EMElissa M. Malkin
Elissa M. Malkin
JCJoseph F. Cortese
Joseph F. Cortese
CPChristopher V. Plowe
Christopher V. Plowe
Molecular assays for monitoring sulfadoxine-pyrimethamine-resistant Plasmodium falciparum have not been implemented because of the genetic and statis

1 January 1999 in The Journal of Pediatrics
Verified
Journal Article
Open access
RORichard A. Oberhelman
Richard A. Oberhelman
RGRobert H. Gilman
Robert H. Gilman
PSPatricia Sheen
Patricia Sheen
DTDavid N. Taylor
David N. Taylor
RBRobert E. Black
Robert E. Black
GMGuillermo Madico
Guillermo Madico
Lactobacillus GG (L-GG), an acid- and bile-resistant strain that colonizes the intestinal mucosa, has been used to manage diarrhea in children. Our objective was to evaluate the prophylactic use of L-GG to prevent diarrhea in children at high risk from a developing country in a randomized, placebo-controlled trial. Two hundred four undernourished children 6 to 24 months old from an indigent peri-urban Peruvian town received either L-GG or placebo in flavored gelatin once daily, 6 days a week, for 15 months. Episodes of diarrhea were documented by daily home visits, and diagnostic studies were done in a subset of cases. Recovery of L-GG in stool from subjects and from family contacts was examined. Subjects in the L-GG group had significantly fewer episodes of diarrhea (5.21 episodes diarrhea/child/year ['ecy'] L-GG group, 6. 02 ecy placebo group; P =.028). The decreased incidence of diarrhea in the L-GG group was greatest in the 18- to 29-month age group (P =. 004) and was largely limited to nonbreastfed children (Breastfed: 6. 59 ecy L-GG, 6.32 ecy placebo, P =.7; Nonbreastfed: 4.69 ecy L-GG, 5. 86 ecy placebo, P =.005). The duration of diarrhea episodes and the causes of diarrhea were similar in both groups, except adenovirus was more common in the placebo group. L-GG supplementation may be useful as a prophylactic measure to control diarrhea in undernourished children at increased risk, especially nonbreastfed children in the toddler age group.

1 March 2002 in Injury Prevention
Verified
Journal Article
Open access
PDF file
JDJ Delgado
J Delgado
MRM E Ramírez-Cardich
M E Ramírez-Cardich
RGR H Gilman
R H Gilman
RLR Lavarello
R Lavarello
NDN Dahodwala
N Dahodwala
ALAndres Lescano
Andres Lescano
Objective: To characterize the presentation of burns in children and risk factors associated with their occurrence in a developing country as a basis for future prevention programs. Design: Case-control study. Setting: Burn unit of the National Institute of Child Health (Instituto Nacional de Salud del Niño) in Lima, Peru. Methods: A questionnaire was administered to all consenting guardians of children admitted to the burns (cases) and general medicine (controls) units during a period of 14 months. Guardians of patients were questioned regarding etiology of the injury, demographic and socioeconomic data. Results: 740 cases and controls were enrolled. Altogether 77.5% of the cases burns occurred in the patient's home, with 67.8% in the kitchen; 74% were due to scalding. Most involved children younger than 5 years. Lack of water supply (odds ratio (OR) 5.2, 95% confidence interval (CI) 2.1 to 12.3), low income (OR 2.8, 95% CI 2.0 to 3.9), and crowding (OR 2.5, 95%CI 1.7 to 3.6) were associated with an increased risk. The presence of a living room (OR 0.6, 95% CI 0.4 to 0.8) and better maternal education (OR 0.6, 95% CI 0.5 to 0.9) were protective factors. Conclusions: To prevent burns interventions should be directed to low socioeconomic status groups; these interventions should be designed accordingly to local risk factors.

1 December 2008 in The Lancet Neurology
Verified
Journal Article
Closed access
TNTheodore E Nash
Theodore E Nash
EPE Javier Pretell
E Javier Pretell
ALAndres Lescano
Andres Lescano
JBJavier A Bustos
Javier A Bustos
RGRobert H Gilman
Robert H Gilman
HGHéctor H Garcia
Héctor H Garcia

1 July 2003 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
BRBaback Roshanravan
Baback Roshanravan
EKElina Kari
Elina Kari
RGRobert H. Gilman
Robert H. Gilman
LCLilia Cabrera
Lilia Cabrera
ELEllen Lee
Ellen Lee
JVJoseph Vinetz
Joseph Vinetz
A cross-sectional study was conducted in the Peruvian Amazon to test the hypothesis that a reservoir of asymptomatic malaria parasitemic patients would form the basis for continuing malaria endemicity in the region. Active surveillance yielded a Plasmodium spp. slide-positive prevalence of 4.2% (43 of 1,023) and a polymerase chain reaction (PCR)–positive prevalence of 17.6% (144 of 819). Plasmodium vivax prevalence was 2.9% and 14.2% while Plasmodium falciparum prevalence was 1.3% and 2.6% by microscopy and PCR, respectively. Approximately two-thirds of slide-positive and one-fourth of PCR-positive people were symptomatic. Anemia was associated with slide positivity (P < 0.001) and PCR positivity for P. falciparum (P = 0.003). Sensitivity of field microscopy and agreement between field and reference laboratory microscopists were low, arguing for using PCR for epidemiologic investigation and malaria control. While these data confirm recent findings from the Brazilian Amazon suggesting that sufficient numbers of asymptomatic malaria parasitemic patients are present to form a persistent reservoir for continuous reinfection within the Peruvian Amazon region, these results also indicate that clinical immunity in human populations can be driven in malaria-endemic regions that do not have high intensity malaria transmission